BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 26370642)

  • 61. Treatment of female pattern hair loss with a combination of spironolactone and minoxidil.
    Hoedemaker C; van Egmond S; Sinclair R
    Australas J Dermatol; 2007 Feb; 48(1):43-5. PubMed ID: 17222303
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Androgenetic alopecia: pathogenesis and potential for therapy.
    Ellis JA; Sinclair R; Harrap SB
    Expert Rev Mol Med; 2002 Nov; 4(22):1-11. PubMed ID: 14585162
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.
    Gassmueller J; Hoffmann R; Webster A
    Br J Dermatol; 2008 Jan; 158(1):109-15. PubMed ID: 17986309
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pediatric androgenetic alopecia: an updated review.
    Gomes TF; Soares RO
    J Dtsch Dermatol Ges; 2023 Jan; 21(1):19-25. PubMed ID: 36688435
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Alopecia: diagnosis and management.
    Nielson TA; Reichel M
    Am Fam Physician; 1995 May; 51(6):1513-22, 1527-8. PubMed ID: 7732952
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee.
    Carmina E; Azziz R; Bergfeld W; Escobar-Morreale HF; Futterweit W; Huddleston H; Lobo R; Olsen E
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2875-2891. PubMed ID: 30785992
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Management of androgenetic alopecia.
    Tosti A; Camacho-Martinez F; Dawber R
    J Eur Acad Dermatol Venereol; 1999 May; 12(3):205-14. PubMed ID: 10461639
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Androgenetic alopecia.
    Piraccini BM; Alessandrini A
    G Ital Dermatol Venereol; 2014 Feb; 149(1):15-24. PubMed ID: 24566563
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Guidelines on the use of finasteride in androgenetic alopecia.
    Mysore V; Shashikumar BM
    Indian J Dermatol Venereol Leprol; 2016; 82(2):128-34. PubMed ID: 26924401
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride.
    Jung JY; Yeon JH; Choi JW; Kwon SH; Kim BJ; Youn SW; Park KC; Huh CH
    Int J Dermatol; 2014 Nov; 53(11):1351-7. PubMed ID: 24898559
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Androgenetic alopecia in men: the scale of the problem and prospects for treatment.
    Rushton DH
    Int J Clin Pract; 1999; 53(1):50-3. PubMed ID: 10344067
    [TBL] [Abstract][Full Text] [Related]  

  • 72. 5α-Reductase inhibitors in men aged 50 years or older with androgenetic alopecia: A retrospective study.
    Kang MJ; Choi JY; Sim WY; Lew BL
    J Am Acad Dermatol; 2021 Jan; 84(1):172-173. PubMed ID: 32320771
    [No Abstract]   [Full Text] [Related]  

  • 73. Mesotherapy with dutasteride for androgenetic alopecia: a concise review of the literature.
    Rodríguez-Cuadrado FJ; Pinto-Pulido EL; Fernández-Parrado M
    Eur J Dermatol; 2023 Feb; 33(1):72. PubMed ID: 37178048
    [No Abstract]   [Full Text] [Related]  

  • 74. Normal and aging hair biology and structure 'aging and hair'.
    Goodier M; Hordinsky M
    Curr Probl Dermatol; 2015; 47():1-9. PubMed ID: 26370639
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Micro needling: A novel therapeutic approach for androgenetic alopecia, A Review of Literature.
    Ocampo-Garza SS; Fabbrocini G; Ocampo-Candiani J; Cinelli E; Villani A
    Dermatol Ther; 2020 Nov; 33(6):e14267. PubMed ID: 32882083
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Adverse Effects of 5-Alpha Reductase Inhibitor Therapy in Men With Androgenetic Alopecia: Is There Cause for Concern?
    Arias-Santiago S; Camacho-Martínez FM
    Actas Dermosifiliogr; 2016 Nov; 107(9):709-711. PubMed ID: 27436801
    [No Abstract]   [Full Text] [Related]  

  • 77. Evaluation of efficacy and safety of finasteride 1 mg in 3177 Japanese men with androgenetic alopecia.
    Sato A; Takeda A
    J Dermatol; 2012 Jan; 39(1):27-32. PubMed ID: 21980923
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Physiology and Medical Treatments for Alopecia.
    Tai T; Kochhar A
    Facial Plast Surg Clin North Am; 2020 May; 28(2):149-159. PubMed ID: 32312501
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Propecia and Rogaine Extra Strength for alopecia.
    Med Lett Drugs Ther; 1998 Feb; 40(1021):25-7. PubMed ID: 9505960
    [No Abstract]   [Full Text] [Related]  

  • 80. Hair loss.
    Patel JC
    Indian J Med Sci; 2000 Mar; 54(3):106-9. PubMed ID: 11227614
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.